NCT00797719 2026-03-05
Short Neoadjuvant Hemithoracic IMRT for MPM
University Health Network, Toronto
Phase 1/2 Completed
Clinical Trials
13 trialsNCT05795595 2025-11-26
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
Phase 1/2 Completed
NCT02649829 2025-04-29
MESODEC
University Hospital, Antwerp
Phase 1/2 Completed
NCT01291420 2024-12-09
Dendritic Cell Vaccination for Patients with Solid Tumors
University Hospital, Antwerp
Phase 1/2 Completed
NCT03399552 2023-10-23
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT02414945 2023-01-10
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
University Health Network, Toronto
Phase 1/2 Completed
NCT02347917 2022-04-12
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
Sumitomo Pharma Co., Ltd.
Phase 1/2 Completed
NCT01644994 2021-09-29
Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma
University of Zurich
Phase 1/2 Completed
NCT00700336 2021-07-20
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
CanBas Co. Ltd.
Phase 1/2 Completed
NCT02049060 2021-01-22
Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin
Istituto Clinico Humanitas
Phase 1/2 Completed
NCT03177668 2020-09-25
Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Kissei Pharmaceutical Co., Ltd.
Phase 1/2 Completed
NCT01721018 2017-06-09
1716-12
Virttu Biologics Limited
Phase 1/2 Completed
NCT01211275 2017-02-28
N08CPA
The Netherlands Cancer Institute
Phase 1/2 Completed